Quantcast

Latest Patent law Stories

2014-05-12 16:28:47

-Revenues Increased 52 Percent- INCLINE VILLAGE, Nev., May 12, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2014. Total revenues for the first quarter of 2014 increased 52 percent to $139.7 million from $91.8 million in the first quarter of 2013. Royalty revenues for the first quarter of 2014 are based on fourth quarter 2013 product sales by PDL's licensees to the Queen et al. patents, royalty...

2014-05-12 16:26:08

Globally acclaimed patent authority World Patent Marketing has recently joined the Association for Manufacturing Excellence to make further improvement of their service. With more than 350 employees, agents and contractors in over four continents, World Patent Marketing is a trusted resource for the inventors to file quality patent applications for the best price in the market. NEW YORK, May 12, 2014 /PRNewswire/ -- World Patent Marketing has recently hit the headlines once again by...

2014-05-12 08:38:10

First of a series of tools enabling public access to actionable patent market data and intelligence SAN FRANCISCO, May 12, 2014 /PRNewswire/ -- RPX Corporation (NASDAQ: RPXC), the leading provider of patent risk management solutions, today launched RPX Search, the first search engine to provide public access to the most complete database that connects patent, litigation, and entity data in one resource. With this free search engine, any company can quickly and accurately search...

2014-05-11 23:02:47

Dr. Yoriko Morita, an English-Japanese fluent senior IP licensing executive, joins General Patent Corporation as Vice President of Licensing to focus on Asian markets. Suffern, N.Y. (PRWEB) May 11, 2014 General Patent Corporation (GPC), a leading patent licensing and IP management firm, has added Dr. Yoriko Morita to its corporate management team as Vice President of Licensing. Dr. Morita is an experienced licensing executive with an extensive IP and technical background. “We are...

2014-05-10 23:01:06

Many pharmaceutical manufacturers will likely derive sales volumes from biological drugs, while also contending with the entrance of biosimilar, or generic biological drugs, into the market. For these reasons, industry research firm IBISWorld has updated a report on the Brand Name Pharmaceutical Manufacturing industry in its growing industry report collection. New York, NY (PRWEB) May 10, 2014 Brand-name pharmaceutical manufacturers have grappled with one of the largest waves of drug...

2014-05-08 20:23:36

DUBLIN, May 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ccwnhk/us_patent) has announced the addition of the "US Patent Practice - What European Patent Attorneys Need to Know (Seminar, London)" [http://www.researchandmarkets.com/research/ccwnhk/us_patent ] conference to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The US Patent Practice - What European Patent Attorneys Need to Know seminar...

2014-05-08 08:43:02

Optimize Content Purchasing and Windowing using New Tool that Unifies Data Across Linear, On Demand, and Hundreds of Digital Platforms NEW YORK, May 8, 2014 /PRNewswire/ -- Content owners were in trouble. With the number of outlets and windows available for content growing exponentially, they struggled to get valid actionable information about usage, revenues, and royalties for their content. Each distribution partner has different, proprietary formats, measures, and schedules for reporting...

2014-05-07 20:24:29

LONDON, May 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cancer Diagnostics Partnering Terms and Agreementshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/cancer_diagnostics_partnering_terms_agreements.htmlThe Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer diagnostics...

2014-05-06 08:42:51

Jim Reddoch, PhD, Royalty Pharma Executive Vice President for Research and Investments Joins Avillion Board LONDON and NEW YORK, May 6, 2014 /PRNewswire/ -- Avillion LLP, a company focused on co-development and financing of late-stage pharmaceutical candidates from Phase 3 clinical development through marketing approval, announced that Royalty Pharma has become an investor, joining Abingworth LLP and Clarus Ventures. Royalty Pharma will be represented on the Avillion Board by Jim...

2014-05-06 08:31:15

Digital marketing patents strengthen RevTrax's proprietary POS validation solutions NEW YORK, May 6, 2014 /PRNewswire/ -- Today, RevTrax announced the acquisition of a patent portfolio including three U.S. patents, three U.S. applications and three foreign applications. The patents disclose a system for secure online distribution and validation of promotions across multiple technologies, including print-at-home, load-to-card, mobile and e-commerce....


Latest Patent law Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related